CLEC5A expressed on myeloid cells as a M2 biomarker relates to immunosuppression and decreased survival in patients with glioma

Cancer Gene Therapy, Published online: 08 October 2019; doi:10.1038/s41417-019-0140-8CLEC5A expressed on myeloid cells as a M2 biomarker relates to immunosuppression and decreased survival in patients with glioma

Source: Cancer Gene Therapy - October 7, 2019 Category: Cancer & Oncology Authors: Luqing Tong Jiabo Li John Choi Ayush Pant Yuanxuan Xia Christopher Jackson Peidong Liu Li Yi Elias Boussouf Michael Lim Xuejun Yang Source Type: research